Nikola Cihoric

FORCE11 Member since July 7, 2017

Help support the FORCE11 community with a donation membership. Click here to learn more.

Biography

EDUCATION

2008 – 2013    Residency In Radiation Therapy, University Hospital Bern, Inselspital

2004 – 2006    Postgraduate Studies, Clinical Pharmacology, Institute for
                        Clinical Pharmacology and Toxicology, School of Medicine, Belgrade

2005                 Object Oriented Programming

Education Centre of the Faculty of Electrical Engineering, Belgrade

1997 – 2003    Medicine Degree At School Of Medicine Belgrade, Belgrade, Serbia

1992 – 1996    Gymnasium, „Jovan Ducic“, Trebinje, Bosnia and Herzegovina

FURTHER EDUCATION (Selection)

2014                Multidisciplinary Management of Breast Cancer, ESTRO School

2011                Drugs Combination in Oncology, ASCO School

2010                Clinical Trial Protocol Development, ESTRO School

2009                Advanced ICH-GCP Training, Clinical Trial Unit University of Bern

2007                Publishing in Biomedicine, School of Medicine Novi Sad

2006                How to Write a Scientific Paper, Lancet & Clinical Centre Zemun, Serbia

2005                ICH-GCP training, ClinTec International, Belgrade

PROFESSIONAL EXPERIENCE

2014 – Dato    Department of Radio-Oncology Inselspital Bern Consultant

2008 – 2013    Department of Radio-Oncology Inselspital Bern Resident  

2008                CRO Galenus  Clinical Research Associate

2006 – 2007    Institute Of Oncology, Department of Radiation Oncology, Belgrade Resident

2005                CRO Acord, Belgrade Clinical Research Associate

                       2003 – 2005    Clinical Centre of Serbia, Belgrade - Compulsory practice

CLINICAL EXPERTISE

Breast Cancer, Gynecological Malignancies, Lung Cancer

Brachytherapy, High Precision External Beam Radiotherapy, Image Guided Radiotherapy, Intensity Modulated Radiotherapy

 

SPECIAL SKILLS

Software Architecture Development,  Python Programming , Data Mining, Text Processing

ADDITIONAL

2016  - clinicatrial.co (www.clinicaltrial.co) A meta-research portal, Founder

Reviewer for

  • Radiation Oncology
  • Cancer Medicine
  • Technology In Cancer Research & Treatment
  • BMJ Open

Languages:  Serbian, English, German

 

PUBLICATIONS AND CONFERENCE PAPERS [1-54]

 

 

1.         Cihoric N, Tsikkinis A, Minniti G, Lagerwaard FJ, Herrlinger U, Mathier E, Soldatovic I, Jeremic B, Ghadjar P, Elicin O: Current status and perspectives of interventional clinical trials for glioblastoma–analysis of ClinicalTrials. gov. Radiation Oncology 2017, 12(1):1.

2.         Tsikkinis A, Cihoric N, Ghadjar P, Loessl K, Aebersold DM, Dal Pra A: Bladder-Preserving Combined-Modality Therapy: What Is Coming Next? A Critical Analysis of Phase 2-3 Trials of the ClinicalTrials. gov Database. International Journal of Radiation Oncology• Biology• Physics 2016, 96(2):E283.

3.         Putora PM, Nikola C, Jan O: PSA tests on Planet Faraway: The Influence of Our Numerical System on Clinical Practice. The Oncologist 2016.

4.         Jeremic B, Cihoric N, Dubinsky P, Filipovic N: Adjuvant immunotherapy in resected early non-small cell lung cancer—battle lost, hopefully not the war! Journal of Thoracic Disease 2016, 8(8):1886.

5.         Jeremic B, Casas F, Dubinsky P, Gomez-Caamano A, Cihoric N, Videtic G: Surgery for stage IIIA non–small-cell lung cancer: Lack of predictive and prognostic factors identifying any subgroup of patients benefiting from it. Clinical lung cancer 2016, 17(2):107-112.

6.         Cihoric N, Tsikkinis A, Miguelez CG, Strnad V, Soldatovic I, Ghadjar P, Jeremic B, Dal Pra A, Aebersold DM, Lossl K: Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials. gov database. Radiation Oncology 2016, 11(1):48.

7.         Cihoric N, Tsikkinis A, Filipovic N, Jeremic B: Treatment options for isolated locoregional recurrences of nonsmall cell lung cancer after surgery: yes, radiation therapy too! European Respiratory Journal 2016, 48(1):276-278.

8.         Tsikkinis A, Cihoric N, Giannarini G, Hinz S, Briganti A, Wust P, Ost P, Ploussard G, Massard C, Surcel CI: Clinical perspectives from randomized phase 3 trials on prostate cancer: an analysis of the ClinicalTrials. gov database. European Urology Focus 2015, 1(2):173-184.

9.         Jeremic B, Cihoric N, Casas F, Gomez-Caamano A, Dubinsky P: No role for trimodality therapy and consolidation chemotherapy compared with concurrent radiochemotherapy alone in stage III non–small-cell lung cancer. Journal of clinical oncology 2015, 34(2):196-197.

10.       Jeremic B, Casas F, Dubinsky P, Cihoric N, Gomez-Caamano A: The Trimodality Treatment Approach in Stage III/pN2 Non–Small Cell Lung Cancer:“Usually Appropriate” May Well be a Very Inappropriate Treatment Option. American journal of clinical oncology 2015, 38(6):645.

11.       Herrmann E, Mertineit N, De Bari B, Hoeng L, Caparrotti F, Jumeau R, Elcin O, Cihoric N, Wolfensberger P, Loessl K: Outcome of Proximal Esophageal Cancer After Definitive Combined Chemoradiation: A Multicenter Retrospective Study. International Journal of Radiation Oncology• Biology• Physics 2015, 93(3):E153.

12.       Grogg A, Trippel M, Pfaltz K, Ladrach C, Droeser RA, Cihoric N, Salhia B, Zweifel M, Tapia C: Androgen receptor status is highly conserved during tumor progression of breast cancer. BMC cancer 2015, 15(1):872.

13.       Cihoric N, Tsikkinis A, van Rhoon G, Crezee H, Aebersold DM, Bodis S, Beck M, Nadobny J, Budach V, Wust P: Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials. gov registry. International journal of hyperthermia 2015, 31(6):609-614.

14.       Cihoric N, Tsikkinis A, Tapia C, Aebersold DM, Zlobec I, Lossl K: Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer. Radiation oncology 2015, 10(1):240.

15.       Cihoric N, Jeremic B: Elective nodal irradiation in early non-small cell lung cancer. In regard to Lao et al. International journal of radiation oncology, biology, physics 2015, 91(5):1111.

16.       Cihoric N, Filipovic N, Jeremic B: A call for careful interpretation of outcome of nonsurgical approach in clinical stage IIIa non-small cell lung cancer in the National Cancer Database. The Annals of thoracic surgery 2015, 99(3):1111-1112.

17.       Bodour Salhia MTKPNCAGCLIZCT: High tumor budding stratifies breast cancer with metastatic properties. Breast Cancer Research and Treatment 2015, 150(2):363-371.

18.       Klass ND, Schmuecking M, Schaefer SC, Fritz E, Baum RP, Cihoric N, Leiser D, Presselt N, Schmid A, Hoksch B: Is Molecular Remission as Detected by 18F-FDG PET/CT and Regression Grade After Neoadjuvant Treatment in the Primary Tumor and the Involved Mediastinal Lymph Nodes a Prognostic Factor in Patients With NSCLC Stage III? International Journal of Radiation Oncology, Biology, Physics 2014, 1(90):S662-S663.

19.       Ghadjar P, Oesch SL, Rentsch CA, Isaak B, Cihoric N, Manser P, Thalmann GN, Aebersold DM: Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer. Radiation oncology 2014, 9(1):122.

20.       Cihoric N, Tsikkinis A, Aebersold DM, Lossl K, Zaugg K: Analysis of clinical trials in radiation oncology: a systematic characterization of the Clinicaltrials. gov database. International Journal of Radiation Oncology, Biology, Physics 2014, 1(90):S581-S582.

21.       Cihoric N, Tapia C, Kruger K, Aebersold DM, Klaeser B, Lossl K: IMRT with 18 FDG-PET\ CT based simultaneous integrated boost for treatment of nodal positive cervical cancer. Radiation oncology 2014, 9(1):83.

22.       Cihoric N, Savic S, Schneider S, Ackermann I, Bichsel-Naef M, Schmid RA, Lardinois D, Gugger M, Bubendorf L, Zlobec I: Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer. British journal of cancer 2014, 110(12):2914-2922.

23.       Frey J, Lossl K, Cihoric N, Mueller M, Gunthert A: Uberleben nach Lymphknotenmetastasen in der Rezidiv-Situation bei Vulvakarzinom. 2013.

24.       Dahdal S, Andres RH, Hewer E, Reubi JC, Klaeser B, Raabe A, Cihoric N, Schmid R, Tanzler K, Krause T: A rare case of a large spinal meningioma with mediastinal extension and malignant behavior classified histologically as benign. In: Theranostics, Gallium-68, and Other Radionuclides. edn.: Springer Berlin Heidelberg; 2013: 443-455.

25.       Cihoric N, Aebersold MD, Terribilini D, Lossl K: PO-0734: Dosimetric parameters of escalated dose radiotherapy in nodal positive cervical cancer patients. Radiotherapy and Oncology 2013, 106:S280.

26.       Belka C, Theissen SM: Radiation Oncology reviewer acknowledgment 2012. Radiation Oncology 2013, 8(1):63.

27.       Schmuecking M, Cihoric N, Klaeser B, Bigler R, Tille J, Fankhauser S, Thomas K, Aebersold D: 303 WHAT IS THE ROLE OF 99MTC-MAA SPECT/CT FOR RADIATION TREATMENT PLANING IN THORACIC TUMORS USING VMAT (RAPIDARC)? Radiotherapy and Oncology 2012, 102:S161-S162.

28.       Cihoric N, Crowe S, Eychmuller S, Aebersold DM, Ghadjar P: Clinically Significant Bleeding in Incurable Cancer Patients: Effectiveness of Hemostatic Radiation Therapy. International Journal of Radiation Oncology* Biology* Physics 2012, 84(3):S627-S628.

29.       Cihoric N, Crowe S, Eychmuller S, Aebersold DM, Ghadjar P: Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy. Radiation oncology 2012, 7(1):132.

30.       Cihoric N, Aebersold D, Kruger K, Lossl K: PD-0303 DOSE ESCALATION IN LOCO-REGIONALLY ADVANCED CERVICAL CANCER USING INTENSITY MODULATED RADIOTHERAPY. Radiotherapy and Oncology 2012, 103:S120.

31.       Loessl K, Cihoric N, Isaak B, Terribilini D, Aebersold DM: 610 poster ACCELERATED PARTIAL BREAST IRRADIATION: A DOSIMETRIC COMPARISON OF PERI-AND POSTOPERATIVE IMPLANTS. Radiotherapy and Oncology 2011, 99:S250.

32.       Blumstein NM, Klaeser B, Cihoric N, Loessl T, Krause T, Aebersold DM: Impact of PET-CT-guided interventions with regard to the therapeutic management of cancer patients planned for radiotherapy: Initial experiences. Technol Cancer Res Treat 2009, 8(2):149-158.

33.       Karapandzic VP, Zoranovic S, Tomasevic A, Rakovic B, Saric M, Radonjic M, Cihoric N: 1311 POSTER Adjuvant radiotherapy of the cervical carcinoma in elderly patients. European Journal of Cancer Supplements 2007, 5(4):177.

34.       Schmuecking M, Klaeser B, Toepfer M, Malthaner M, Frueh M, Schmidhalter D, Cihoric N, Blumstein N, Born E, Plasswilm L: Non-gated F-18 FDG PET/CT for target volume delineation in stereotactic body radiation therapy (SBRT) in patients with malignant lung lesions and clinical outcome. In: 2012: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 95-95.

35.       Schmuecking M, Klaeser B, Bigler R, Klass ND, Hentschel M, Cihoric N, Tille J, Fankhauser S, Boy C, Krause T: What is the role of 99mTc-MAA SPECT/CT for radiation treatment planning in thoracic tumors using VMAT? In: 2012: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 94-94.

36.       Mertineit N, Cihoric N, Leiser D, Aebersold DM, Herrmann E: Locoregional control of proximal esophageal cancer after definitive radio-/chemotherapy. In: 2015: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 95-95.

37.       Loessl K, Cihoric N, Isaak B, Terribilini D, Aebersold DM: Accelerated partial breast irradiation (apbi) with multicatheter brachytherapy (mcb): experience of a single institution. In: 2015: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 83-83.

38.       Klass ND, Klaeser B, Topfer M, Malthaner M, Fruh M, Schmidhalter D, Cihoric N, Born E, Blumstein N, Plasswilm L: Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome. In: 2012: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 742-743.

39.       Klass ND, Boy C, Klaeser B, Bigler R, Hentschel M, Cihoric N, Tille J, Krause T, Aebersold DM, Schmuecking M: Is there a role of 99MTC-MAA spect/CT for radiation treatment planning in thoracic tumors using VMAT? In: 2012: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 727-728.

40.       Jeremic B, Filipovic N, Casas F, Cihoric N, Dukic T: Metal-enhanced radiotherapy: Gold nanoparticles and beyond. In: 2015.

41.       Herrmann E, Mertineit N, De-Bari B, Hoeng L, Caparrotti F, Jumeau R, Elicin O, Cihoric N, Wolfensberger P, Loessl T: Outcome of Proximal Esophageal Cancer After Definitive Combined Chemo-Radiation: A Multicenter Swiss Retrospective Study. In: 2015: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 901-901.

42.       Cihoric N, Zaugg K, Tsikkinis A, Aebersold MD, Leiser D, Loessl K: Landscape of radiation-oncology clinical trials in gynecological malignancies: comprehensive analysis of clinicaltrial. gov database. In: 2015: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 100-100.

43.       Cihoric N, Trajkovic G, Aebersold DM, Loessl K: INTENSITY MODULATED RADIOTHERAPY (IMRT) IN THE TREATMENT OF CERVICAL CANCER PATIENTS-OUR EXPERIENCE. In: 2010: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 742-742.

44.       Cihoric N, Rabaglio M, Aebersold DM, Loessl K: VMAT radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer. In: 2015: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 98-98.

45.       Cihoric N, Mackeprang P-H, Shelan M, Tsikkinis A, Aebersold DM, Putora PM: Radiotherapy data are conformal to Benford's Law. Implication for research and practice. In: 2016: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 871-872.

46.       Cihoric N, Leiser D, Terribilini D, Bigler R, Loessl K: Comparison of 3DCRT, IMRT and VMAT treatment plans for bilateral breast cancer. In: 2013: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 1083-1083.

47.       Cihoric N, Leiser D, Aebersold MD, Frey J, Guenthert A, Loessl K: Outcome of patients with vulvar cancer treated with postoperative IMRT. In: 2013: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 1072-1072.

48.       Cihoric N, Krueger K, Klaeser B, Aebersold DM, Loessl K: 18FDG PET-CT based simultaneous integrated boost for treatment of loco-regionally advanced cervical cancer. In: 2012: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 727-727.

49.       Cihoric N, Klaeser B, Aebersold DM, Loessl K: TREATMENT RESPONSE IN FDG-PET-BASED TREATMENT PLANNING FOR DOSE ESCALATION IN LOCOREGIONAL ADVANCED CERVICAL CANCER. In: 2010: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 723-723.

50.       Cihoric N, Broemme J, Arnold A, Geretschlaeger A, Giger R, Aebersold DM, Krause T, Klaeser B, Schmuecking M: Detection of systemic metastases and secondary malignant tumors by 18F-FDG PET/CT in head and neck squamous cell carcinoma (HNSCC). In: 2013: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 1087-1087.

51.       Cihoric N, Aebersold DM, Trajkovic G, Loessl K: LOCAL FAILURE IN BREAST-CONSERVING THERAPY WITH REGARD TO LOCALISATION AND DOSE OF RADIOTHERAPY. In: 2010: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY: 722-722.

52.       Jeremic B, Casas F, Dubinsky P, Gomez-Caamano A, Cihoric N, Videtic G, Latinovic M: Combined modality therapy in Stage IIIA non-small cell lung cancer: clarity or confusion despite the highest level of evidence? J Radiat Res 2017, 58(3):267-272.

53.       Herrmann E, Mertineit N, De Bari B, Hoeng L, Caparotti F, Leiser D, Jumeau R, Cihoric N, Jensen AD, Aebersold DM et al: Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study. Radiat Oncol 2017, 12(1):97.

54.       Cihoric N, Badra EV, Lossl K: In Regard to Derks et al: Type of Radiotherapy Is Important for Quality of Life. International Journal of Gynecological Cancer 2017.